Search Results - "Raitanen, M"

Refine Results
  1. 1

    Immunonutrition in Elective Gastrointestinal Surgery Patients by Helminen, H., Raitanen, M., Kellosalo, J.

    Published in Scandinavian journal of surgery (01-01-2007)
    “…Background: Previous trials have shown that perioperative immunonutrition could protect patients from infectious complications after gastrointestinal cancer…”
    Get full text
    Journal Article
  2. 2

    Analysis of false-positive BTA stat test results in patients followed up for bladder cancer by Raitanen, Mika-P, Kaasinen, Eero, Lukkarinen, Olavi, Kauppinen, Risto, Viitanen, Jouko, Liukkonen, Tapani, Tammela, Teuvo L.J

    Published in Urology (Ridgewood, N.J.) (01-04-2001)
    “…Objectives. To evaluate the role of a positive BTA stat Test result in patients with negative cystoscopic findings. Methods. Five hundred one consecutive…”
    Get full text
    Journal Article
  3. 3

    Prognostic utility of human complement factor H related protein test (the BTA Test) by RAITANEN, M-P, KAASINEN, E, RINTALA, E, HANSSON, E, NIEMINEN, P, AINE, R, TAMMELA, T. L. J

    Published in British journal of cancer (17-08-2001)
    “…The purpose of the study was to determine, in addition to well-known prognostic factors, histological grade, stage, tumour size and multiplicity, the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test by Raitanen, M P, Hellström, P, Marttila, T, Korhonen, H, Talja, M, Ervasti, J, Tammela, T L

    Published in European urology (01-10-2001)
    “…The BTA stat is a rapid, non-invasive, qualitative urine test that detects bladder tumor-associated antigen (human complement factor H related protein) in…”
    Get more information
    Journal Article
  6. 6

    Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer by Raitanen, M P, Marttila, T, Kaasinen, E, Rintala, E, Aine, R, Tammela, T L

    Published in The Journal of urology (01-06-2000)
    “…We compared the sensitivity of the BTA statdagger test, a rapid, noninvasive, qualitative urine test that detects bladder tumor associated antigen (human…”
    Get more information
    Journal Article
  7. 7

    Mutations of TP53 do not correlate with the sensitivity to paclitaxel—a study using 27 gynaecological cancer cell lines by Rantanen, V, Engblom, P, Raitanen, M, Hietanen, S, Haarala, M, Grénman, S, Syrjänen, S

    Published in European journal of cancer (1990) (01-09-2002)
    “…The correlation between inactivation of the TP53 gene through mutation or the presence of high-risk human papillomavirus (HPV) DNA and intrinsic paclitaxel…”
    Get full text
    Journal Article
  8. 8

    P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer by Raitanen, M P, Tammela, T L, Kallioinen, M, Isola, J

    Published in The Journal of urology (01-04-1997)
    “…The alterations in deoxyribonucleic acid (DNA) ploidy and p53 expression during progression of bladder cancer were determined. p53 Expression and DNA ploidy…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Human complement factor H related protein test for monitoring bladder cancer by Raitanen, M P, Marttila, T, Nurmi, M, Ala-Opas, M, Nieminen, P, Aine, R, Tammela, T L

    Published in The Journal of urology (01-02-2001)
    “…The BTA stat test is a rapid, noninvasive, qualitative urine test that detects bladder tumor associated antigen (human complement factor H related protein) in…”
    Get more information
    Journal Article
  11. 11

    Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder by Raitanen, M P, Nieminen, P, Tammela, T L

    Published in British journal of urology (01-10-1995)
    “…To evaluate the impact of the grade, stage number and size of the tumour and of smoking and sex of patient on survival, and the relationship between smoking…”
    Get more information
    Journal Article
  12. 12

    Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer by Liukkonen, T J; O, Lipponen, P K, Helle, M, Jauhiainen, K E

    Published in Urolithiasis (01-02-1997)
    “…Immunoreactivity of bcl-2, p53, the epidermal growth factor (EGFr) and Ki-67 (MIB-1) proteins was assessed by immunohistochemistry in 185 patients with…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive? by Raitanen, M-P, Aine, R A T, Kaasinen, E S, Liukkonen, T J O, Kylmälä, T M, Huhtala, H, Tammela, T L J

    “…Urine cytology is the gold standard in the diagnosis and follow-up of bladder cancer. Cytology, however, exhibits variable sensitivity depending on tumour…”
    Get more information
    Journal Article
  15. 15

    Complement Factor H as a Marker for Detection of Bladder Cancer by Cheng, Zhu-Zhu, Corey, Michael J, Parepalo, Maria, Majno, Sandra, Hellwage, Jens, Zipfel, Peter F, Kinders, Robert J, Raitanen, Mika, Meri, Seppo, Jokiranta, T. Sakari

    Published in Clinical chemistry (Baltimore, Md.) (01-05-2005)
    “…The BTA TRAK and BTA stat tests for bladder cancer use monoclonal antibodies (mAbs) X13.2 and X52.1 to detect factor H (FH)-related material in urine. The…”
    Get full text
    Journal Article
  16. 16

    Charge-dependent Targeting: Results in Six Tumor Cell Lines by MARQUEZ, Marcela, NILSSON, Sten, LENNARTSSON, Lena, ZHAOXU LIU, TAMMELA, Teuvo, RAITANEN, Mika, HOLMBERG, Anders R

    Published in Anticancer research (01-05-2004)
    “…Background: Many previous studies show that cell surface sialylation of malignant cells is enhanced compared to normal tissue. The carboxyl group of the sialic…”
    Get full text
    Journal Article
  17. 17

    Specificity of human complement factor H-related protein test (Bard BTA stat Test) by Raitanen, M P, Tammela, T L

    “…The Bard BTA stat Test is a new, rapid, non-invasive qualitative test that detects bladder tumour-associated antigen (human Complement Factor H-related…”
    Get more information
    Journal Article
  18. 18

    Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder by Raitanen, M P, Tammela, T L

    “…The recurrence rate and the time interval until the first recurrence were analysed in 169 consecutive conservatively treated patients with transitional cell…”
    Get more information
    Journal Article
  19. 19

    Identification of individual genes altered in squamous cell carcinoma of the vulva by Kunjoonju, Josena P., Raitanen, Misa, Grénman, Seija, Tiwari, Nivedita, Worsham, Maria J.

    Published in Genes chromosomes & cancer (01-10-2005)
    “…Chromosome rearrangements in squamous cell carcinoma of the vulva (SCV) have indicated common consistent regions of loss and gain. The overall aim of our…”
    Get full text
    Journal Article
  20. 20